Genetic Technologies Ltd. (Nasdaq: GENE) announced that two additional breast
health centers will offer BREVAGenplus to their patients sending the stock price soaring $1.18 to $5.41.
Genetic Technologies adds two health centers
April 20, 2015 at 12:41 PM EDT
